$5MRound, 9 September 2025
Funds GMP manufacturing transfer and clinical translation ahead of a Phase I/IIa trial.
- Amount
- $5M
- Announced
- 9 September 2025
- Lead
- Taiho Ventures
- Other investors
- Kizoo Technology Capital, Beiersdorf Venture Capital
- Use of funds
- Funds GMP manufacturing transfer and clinical translation ahead of a Phase I/IIa trial.
- Checked
- Amount and date matched across 2 press sources
- Sources
- cellvie raises €4.3M (Undisclosed) - Tech.eu Funding Explorer startupticker.ch
cellvie raises €4.3M (Undisclosed) - Tech.eu Funding Explorer funding.tech.eu